PIK3CA and neoplasm: Importantly, we also assessed whether the combination of PQR309 with gemcitabine could exhibit synergistic anti-tumor effects in HK-1 and C666-1 cells with wild-type PIK3CA. This combined therapy significantly increased apoptosis, anti-colony-forming effects, and notably inhibited NPC cell migration and invasion.